81 related articles for article (PubMed ID: 31334108)
1. Modulation Effects of the CEP128 Gene on Radiotherapy-Related Brain Injury: A Longitudinal Structural Study Using Multi-Parametric Brain MR Images.
Lin S; Lv X; Lin X; Chen S; Li Y; Xu M; Qiu Y; Tang L
J Magn Reson Imaging; 2024 Feb; 59(2):648-658. PubMed ID: 37249021
[TBL] [Abstract][Full Text] [Related]
2. Altered neural intrinsic oscillations in patients with multiple sclerosis: effects of cortical thickness.
Liang X; Wang L; Zhu Y; Wang Y; He T; Wu L; Huang M; Zhou F
Front Neurol; 2023; 14():1143646. PubMed ID: 37818221
[TBL] [Abstract][Full Text] [Related]
3. Application value of 3D pCASL in early assessment of potential radiation encephalopathy in nasopharyngeal carcinoma patients undergoing radiotherapy.
He Y; Guo J; Ding Y; Zhou L; Jiang X; Zhen C; Wu Q
Br J Radiol; 2023 Sep; 96(1149):20200448. PubMed ID: 37393533
[TBL] [Abstract][Full Text] [Related]
4. MRI-based radiomics models for the early prediction of radiation-induced temporal lobe injury in nasopharyngeal carcinoma.
Huang L; Yang Z; Zeng Z; Ren H; Jiang M; Hu Y; Xu Y; Zhang H; Ma K; Long L
Front Neurol; 2023; 14():1135978. PubMed ID: 37006478
[TBL] [Abstract][Full Text] [Related]
5. Functional changes of the prefrontal cortex, insula, caudate and associated cognitive impairment (chemobrain) in NSCLC patients receiving different chemotherapy regimen.
Liu S; Ni J; Yan F; Yin N; Li X; Ma R; Wu J; Zhou G; Feng J
Front Oncol; 2022; 12():1027515. PubMed ID: 36408140
[TBL] [Abstract][Full Text] [Related]
6. Surface-Based Falff: A Potential Novel Biomarker for Prediction of Radiation Encephalopathy in Patients With Nasopharyngeal Carcinoma.
Zhang YM; Kang YF; Zeng JJ; Li L; Gao JM; Liu LZ; Shi LR; Liao WH
Front Neurosci; 2021; 15():692575. PubMed ID: 34349618
[TBL] [Abstract][Full Text] [Related]
7. Irradiation-related longitudinal white matter atrophy underlies cognitive impairment in patients with nasopharyngeal carcinoma.
Lin X; Tang L; Li M; Wang M; Guo Z; Lv X; Qiu Y
Brain Imaging Behav; 2021 Oct; 15(5):2426-2435. PubMed ID: 33474681
[TBL] [Abstract][Full Text] [Related]
8. Concurrent chemoradiotherapy in the management of advanced nasopharyngeal carcinoma: current status.
Afqir S; Ismaili N; Errihani H
J Cancer Res Ther; 2009; 5(1):3-7. PubMed ID: 19293481
[TBL] [Abstract][Full Text] [Related]
9. Impairment mechanism of nasal mucosa after radiotherapy for nasopharyngeal carcinoma.
Fang C; Zhong Y; Chen T; Li D; Li C; Qi X; Zhu J; Wang R; Zhu J; Wang S; Ruan Y; Zhou M
Front Oncol; 2022; 12():1010131. PubMed ID: 36591522
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy Potentially Facilitates the Occurrence of Radiation Encephalopathy in Patients With Nasopharyngeal Carcinoma Following Radiotherapy: A Multiparametric Magnetic Resonance Imaging Study.
Zhang Y; Yi X; Gao J; Li L; Liu L; Qiu T; Zhang J; Zhang Y; Liao W
Front Oncol; 2019; 9():567. PubMed ID: 31334108
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced abnormal cortical thickness in patients with nasopharyngeal carcinoma after radiotherapy.
Lin J; Lv X; Niu M; Liu L; Chen J; Xie F; Zhong M; Qiu S; Li L; Huang R
Neuroimage Clin; 2017; 14():610-621. PubMed ID: 28348952
[TBL] [Abstract][Full Text] [Related]
12. Pre-symptomatic local brain activity and functional connectivity alterations in nasopharyngeal carcinoma patients who developed radiation encephalopathy following radiotherapy.
Zhang YM; Gao JM; Zhou H; Li L; Liu LZ; Han ZD; Yi XP; Liao WH
Brain Imaging Behav; 2020 Oct; 14(5):1964-1978. PubMed ID: 31264197
[TBL] [Abstract][Full Text] [Related]
13. Interaction of chemotherapy and radiotherapy in altering the shape of subcortical structures in patients with nasopharyngeal carcinoma.
Nan F; Gao JM; Li L; Zhang YM; Zhang Y
Front Oncol; 2022; 12():952983. PubMed ID: 36172168
[TBL] [Abstract][Full Text] [Related]
14. Network-level dysconnectivity in patients with nasopharyngeal carcinoma (NPC) early post-radiotherapy: longitudinal resting state fMRI study.
Qiu Y; Guo Z; Han L; Yang Y; Li J; Liu S; Lv X
Brain Imaging Behav; 2018 Oct; 12(5):1279-1289. PubMed ID: 29164505
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
